Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.4 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

Marekani - Kiingereza - NLM (National Library of Medicine)

medical purchasing solutions, llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride injection usp is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride injection usp in these patients. bupivacaine hydrochloride injection usp is not recommended for intravenous regional anesthesia (bier block). see warnings . the routes of administration and indicated bupivacaine hydrochloride injection usp concentrations are: - local infiltration                          0.25% - peripheral nerve block               0.25% and 0.5% - retrobulbar block                       0.75% - sympathetic block                     0.25% - lumbar epidural         

Marekani - Kiingereza - NLM (National Library of Medicine)

auromedics pharma llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride injection usp is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride injection usp in these patients. bupivacaine hydrochloride injection usp is not recommended for intravenous regional anesthesia (bier block). see warnings . the routes of administration and indicated bupivacaine hydrochloride injection usp concentrations are: - local infiltration                          0.25% - peripheral nerve block               0.25% and 0.5% - retrobulbar block                       0.75% - sympathetic block                     0.25% - lumbar epidural                         0.25%, 0.5%, and 0.75% (0.75% not for obstetrica

Marekani - Kiingereza - NLM (National Library of Medicine)

remedyrepack inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings ). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block) (see warnings ). the routes of administration and indicated bupivacaine hydrochloride concentrations are: •local infiltration 0.25% •peripheral nerve block 0.25% and 0.5% •retrobulbar block 0.75% •sympathetic block 0.25% •lumbar epidural 0.25%, 0.5%, and 0.75% (0.75% not for obstetrical anesthesia) •caudal 0.25% and 0.5% •epidural test dose 0.5% with epinephrine 1:200,000 •d

Marekani - Kiingereza - NLM (National Library of Medicine)

remedyrepack inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride injection, usp is indicated for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride injection, usp in these patients. bupivacaine hydrochloride injection, usp is not recommended for intravenous regional anesthesia (bier block). see warnings . the routes of administration and indicated bupivacaine hydrochloride injection, usp concentrations are: - local infiltration                          0.25% - peripheral nerve block               0.25% and 0.5% - retrobulbar block                       0.75% - sympathetic block                     0.2

Marekani - Kiingereza - NLM (National Library of Medicine)

huons co., ltd. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride in dextrose injection, usp is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia). bupivacaine hydrochloride in dextrose injection, usp is contraindicated in: - intravenous regional anesthesia (bier block) [ see warnings and precautions (5.8) ]. - patients with septicemia. - patients with severe hemorrhage, severe hypotension or shock, due to a reduced cardiac output. - patients with clinically significant arrhythmias, such as complete heartblock, due a reduced cardiac output. - patients with a known hypersensitivity to bupivacaine or to any local anesthetic agent of the amide-type or to other components of bupivacaine hydrochloride in dextrose injection, usp. - patients with local infection at the site of proposed lumbar puncture. risk summary the available data on the use of bupivacaine hydrochloride in dextrose injection, usp in pregnant women do not establish the presence or absence of developmental toxicity related

Marekani - Kiingereza - NLM (National Library of Medicine)

asclemed usa, inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride injection, usp is indicated for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride injection, usp in these patients. bupivacaine hydrochloride injection, usp is not recommended for intravenous regional anesthesia (bier block). see warnings . the routes of administration and indicated bupivacaine hydrochloride injection, usp concentrations are: - local infiltration                          0.25% - peripheral nerve block               0.25% and 0.5% - retrobulbar block                       0.75% - sympathetic block                     0.2

Marekani - Kiingereza - NLM (National Library of Medicine)

asclemed usa, inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride injection, usp is indicated for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride injection, usp in these patients. bupivacaine hydrochloride injection, usp is not recommended for intravenous regional anesthesia (bier block). see warnings . the routes of administration and indicated bupivacaine hydrochloride injection, usp concentrations are: - local infiltration                          0.25% - peripheral nerve block               0.25% and 0.5% - retrobulbar block                       0.75% - sympathetic block                     0.2

Marekani - Kiingereza - NLM (National Library of Medicine)

medical purchasing solutions, llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings ). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block) (see warnings ). the routes of administration and indicated bupivacaine hydrochloride concentrations are: •local infiltration 0.25% •peripheral nerve block 0.25% and 0.5% •retrobulbar block 0.75% •sympathetic block 0.25% •lumbar epidural 0.25%, 0.5%, and 0.75% (0.75% not for obstetrical anesthesia) •caudal 0.25% and 0.5% •epidural test dose 0.5% with epinephrine 1:200,000 •d

Kanada - Kiingereza - Health Canada

omega laboratories limited - bupivacaine hydrochloride - solution - 7.5mg - bupivacaine hydrochloride 7.5mg - local anesthetics